Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Therapeutic utilization in chronic lymphocytic leukemia: A cross-sectional analysis of the Lymphoma Coalition’s 2022 Global Patient Survey.

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSteve E. KallogerAWAmanda J. WatsonSSShawn Sajkowski

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kalloger et al. (2024) studied this question.

synapsesocial.com/papers/68e673edb6db6435875fe063https://doi.org/10.1200/jco.2024.42.16_suppl.e19026
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemo ± immunotherapy remains utilized for chronic lymphocytic lymphoma in the real-world practice: Unmet needs, treatment patterns, and age disparities in the United States2025
  2. 2A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022)2024 · 7 citations
  3. 3Frontline therapy patterns and outcomes in chronic lymphocytic leukemia: A real-world, multicenter analysis from Latin America.2025
  4. 4A decade of progress: A comparative analysis of real-world survival in chronic lymphocytic leukemia across therapeutic eras2025
  5. 5Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013–2022 in Finland2025